Related Experiment Videos

Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice

Insights

Host genetics influence coxsackievirus myocarditis. Immune responses, specifically cellular immunity in Balb/c and autoantibodies in DBA/2 mice, drive myocardial damage, highlighting distinct immune mechanisms in viral heart disease.

Area of Science:

  • Immunology
  • Virology
  • Cardiovascular Science

Background:

  • Coxsackievirus B3 (CVB3) infection can cause myocarditis, inflammation of the heart muscle.
  • Genetic background significantly impacts disease severity in viral myocarditis models.
  • Previous studies suggest a role for the immune system in CVB3-induced heart disease.

Purpose of the Study:

  • To investigate the role of host genetic factors in CVB3 myocarditis pathogenesis.
  • To elucidate the specific immune mechanisms responsible for myocardial injury in different mouse strains.
  • To determine the contribution of cellular immunity versus autoantibodies in CVB3-induced heart damage.

Main Methods:

  • Infection of DBA/2, Balb/c (H-2d), and C57Bl/6 (H-2b) mice with a heart-adapted CVB3 strain.
  • Assessment of myocardial inflammation, necrosis, and viral titers.
  • Immunomodulation using anti-mouse thymocyte serum, anti-Iad antibody, and complement depletion (cobra venom factor).
  • Analysis of cytolytic T lymphocyte activity and heart-reactive autoantibodies.

Main Results:

  • DBA/2 and Balb/c mice developed significant myocarditis, while C57Bl/6 mice showed minimal inflammation despite similar viral loads.
  • Immune suppression (anti-thymocyte serum, anti-Iad antibody) prevented myocarditis in susceptible strains.
  • Balb/c mice primarily exhibited myocardial injury mediated by cellular immunity.
  • DBA/2 mice showed abrogation of myocarditis upon complement depletion, indicating a role for heart-reactive antibodies.

Conclusions:

  • Host genetic background dictates susceptibility and pathogenesis of CVB3 myocarditis.
  • Distinct immune mechanisms, cellular immunity in Balb/c and autoantibodies in DBA/2, drive myocardial damage.
  • Targeting specific immune pathways may offer therapeutic strategies for viral myocarditis.

Related Concept Videos